Accession |
PRJCA010947 |
Title |
A randomized, open-label, single-dose, two-treatment, two-period, two-way crossover bioequivalence study of febuxostat tablets in healthy subjects under fasting conditions |
Relevance |
Medical |
Data types |
clinical study
|
Organisms |
Homo sapiens
|
Description |
The study objectives are to compare and evaluate the bioequivalence of Febuxostat Tablets 80 mg in healthy, adult, human subjects under fasting conditions and to monitor the safety of the subjects. |
Sample scope |
homo sapiens |
Release date |
2024-08-02 |
Grants |
Agency |
program |
Grant ID |
Grant title |
No funding support
|
|
|
|
|
Submitter |
Liping
Chen (chenliping@huahaipharm.com)
|
Organization |
Zhejiang Huahai Pharmaceutical Co., Ltd |
Submission date |
2022-08-02 |